Study of DF6215 in Patients With Advanced Solid Tumors
Dragonfly Therapeutics
Dragonfly Therapeutics
Seagen Inc.
Seagen Inc.
Centre Oscar Lambret
PMV Pharmaceuticals, Inc
EpiBiologics
Hoffmann-La Roche
Hoffmann-La Roche
Boehringer Ingelheim
Aktis Oncology, Inc.
University of California, Irvine
ViroMissile, Inc.
Duke University
AstraZeneca
Pfizer
Tizona Therapeutics, Inc
M.D. Anderson Cancer Center
ALX Oncology Inc.
Betta Pharmaceuticals Co., Ltd.
University of Colorado, Denver
Karolinska University Hospital
UNC Lineberger Comprehensive Cancer Center
Daiichi Sankyo
SN BioScience
Oscotec Inc.
Kidney Cancer Research Bureau
Perspective Therapeutics
Second Life Therapeutics
Onchilles Pharma Inc
Boehringer Ingelheim
Eli Lilly and Company
Varian, a Siemens Healthineers Company
Novartis
UNICANCER
Varian, a Siemens Healthineers Company
I-Mab Biopharma US Limited
VM Oncology, LLC
Pfizer
Takeda
BicycleTx Limited
Bolt Biotherapeutics, Inc.
Astellas Pharma Inc
Tempus AI
Eli Lilly and Company
Actym Therapeutics, Inc.
Memorial Sloan Kettering Cancer Center
Maastricht Radiation Oncology
Sichuan Baili Pharmaceutical Co., Ltd.
LigaChem Biosciences, Inc.
British Columbia Cancer Agency